Dose Reference Table

Pre-calculated for a 5mg vial + 2ml BAC water = 2,500 mcg/ml concentration. Using a 100-unit (1ml) insulin syringe.

Dose Inject Volume (ml) Syringe Units
50mcg 0.020 ml 2 units
100mcg 0.040 ml 4 units
150mcg 0.060 ml 6 units
200mcg 0.080 ml 8 units
300mcg 0.120 ml 12 units

About Hexarelin

Hexarelin is a synthetic hexapeptide and potent GHRP (Growth Hormone-Releasing Peptide) that stimulates GH release from the pituitary gland. It is one of the most potent GHRPs studied, with a higher GH-stimulating efficacy than GHRP-6 or Ipamorelin. Beyond GH secretion, hexarelin has been studied for its cardioprotective properties — it binds to CD36 receptors on cardiac tissue, making it unique among GHRPs.

Hexarelin's cardiovascular research angle is particularly interesting: studies have demonstrated protective effects on cardiac function independent of GH release, suggesting direct mechanisms at the heart level. This has led to research into hexarelin for cardiac protection, recovery from ischemic events, and heart failure models.

Hexarelin is supplied in 5mg vials. Using 2ml of bacteriostatic water gives 2,500 mcg/ml. Common research doses range from 100–200mcg per injection, 2–3 times daily. Note that hexarelin can produce desensitization (reduced response) with prolonged continuous use — research protocols often cycle its use.

Frequently Asked Questions

Common research doses range from 100–200mcg per injection, 2–3 times daily. For a 5mg vial + 2ml BAC water (2500 mcg/ml), 100mcg = 0.04ml = 4 units.
Hexarelin is generally considered more potent than GHRP-6 for GH release. However, GHRP-6 is better studied and hexarelin may cause faster desensitization with continuous use.
Yes — hexarelin is known to cause receptor desensitization with prolonged continuous use, meaning GH release diminishes over time. Many research protocols cycle hexarelin (e.g., 8 weeks on, 4 weeks off) to maintain responsiveness.
For maximal GH response, hexarelin is typically administered in a fasted state — upon waking (before breakfast) or before bed. Elevated blood glucose blunts GH response.
Hexarelin binds to CD36 receptors on cardiac tissue, and animal studies have shown protection against ischemic injury, improved cardiac function, and potential anti-fibrotic effects. This is an active area of research.